ANN NANTEZA SENGENDO
ID:
|
Assessment of integrated control of East Coast fever (ECF) by induction of acquired immunity in Ankole cattle after natural infection by early diagnosis and early treatment
REFNo: A134ES
Mainobjective
To investigate the performance of early diagnosis and early treatment of ECF as a method of reducing calf mortality and enhancing conditions for the development of endemic stability
Specific objectives
i. To determine the prevalence of ECF based on microscopic, ELISA and PCR methods.
ii. To determine the efficiency of early symptom diagnosis and early chemotherapy approach in treating natural ECF cases and induction of protective immunity against ECF in Ankole cattle in an endemic area.
iii. To design a diagnostic regimen/protocol that farmers can use to minimize cattle losses due to ECF by integrating early case symptom detection and early treatment in the routine control strategy in an endemic area.
|
Uganda |
2021-08-03 |
2024-08-03 |
Agricultural Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Kenneth Rubango
ID:
|
Feasibility Study of Nanomedicine in Uganda
REFNo: HS1485ES
Design a nanomedicine promotion package that will be shared with Makerere University, the Ministry of Health and the other healthcare providers. ,Study and evaluate the effectiveness of nanomedicine towards the existing medical education in the selected medical schools. Under this aim, the teaching staff e.g Assistant lecturers, Lecturers, Associate Professors or Professors will be interviewed for the necessary information.,Engage employers and employees in designing the feasibility study towards nanomedicine at their workplaces. Under this aim, the employers e.g Administrators, Principals or Human resource managers will be interviewed for the necessary information.,Assess employer’s willingness to support interventions geared at promoting nanomedicine at their workplaces. Under this aim, the employers e.g Administrators, Principals or Human resource managers will be interviewed for the necessary information.,Conduct formative research to assess existing and needed support for nanomedicine in the selected medical schools. Under this aim, the Key Informant person from each medical school will be interviewed. ,To design and evaluate the feasibility study of nanomedicine in the selected Ugandan medical schools.,
|
Uganda |
2021-08-03 |
2024-08-03 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Cally Tann
ID: UNCST-2023-R008021
|
Transitioning a Bundle for Early Detection and Intervention for Children with Developmental Disability to Scale for Low-Resource Settings
REFNo: SS910ES
WS1: To develop harmonised training materials to promote and support high fidelity implementation of the PDC and ABAaNA EIP at scale.
WS2: To further develop the Ubuntu multi-media web platform including development of a pilot mobile tablet application to promote programme accessibility and fidelity.
WS3: To identify existing approaches to livelihood support for caregivers of children with developmental disability in low- and middle-income countries to inform the development of a livelihoods component to the EIP.
WS4: To develop a scale-up strategy, business model and marketing strategy to disseminate the PDC and EIP approaches to a wider audience.
WS5: To define a sustainable monitoring, evaluation and learning strategy to track implementation of the PDC and EIP at scale
|
UK |
2021-08-03 |
2024-08-03 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Frederick Kijjambu Nsambu
ID:
|
PERFORMANCE OF MICROFINANCE DEPOSIT TAKING INSTITUTIONS; A MACROECONOMIC AND INSTITUTIONAL PERSPECTIVE IN UGANDA
REFNo: SS932ES
5To establish the relationship between ownership structure and performance of MDI in Uganda. ,i4 To establish the competition on the performance of MDIs in Uganda.,3To establish the impact of outreach on performance of MDIs in Uganda.,To establish the impact of external factors on the performance of MDIs in Uganda.,To establish the impact of internal factors on the performance of MDIs in Uganda.,To establish performance of microfinance deposit taking institutions in Uganda,
|
Uganda |
2021-08-03 |
2024-08-03 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Moses Joloba Lutaakome
ID: UNCST-2022-R011558
|
Validation of the new BP- TB LAM LFA test in well-defined urine and plasma samples collected from TB patients irrespective of HIV status
REFNo: HS1527ES
Primary:
• To collect urine and plasma samples for validation studies on the selection of the best prototype among the six TB LAM LFA prototypes generated by Biopromic (BP)
Secondary:
• To create a biobank of plasma and urine for future validation of novel TB diagnostics
|
Uganda |
2021-08-03 |
2024-08-03 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|